Product image of Zercepac (Trastuzumab) supplied by GNH India

Zercepac

Active Ingredient:
Trastuzumab
Origin:
EU

Zercepac (Trastuzumab)

Zercepac (trastuzumab) is a targeted therapy for HER2-positive breast cancer and metastatic gastric cancer. Administered intravenously, it works by binding to HER2 receptors to slow tumor growth. This monoclonal antibody is widely prescribed in oncology settings. Short version: Zercepac (trastuzumab) treats HER2-positive breast and gastric cancers via IV infusion, slowing tumor progression with targeted action.

Manufacturer / TM Owner

Accord Healthcare S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zercepac (trastuzumab) is used to treat HER2-positive breast cancer in both early and metastatic stages. It is also indicated for HER2-positive metastatic gastric cancer when combined with chemotherapy. Patients often ask, 'What is trastuzumab used for?'—this medication targets HER2 receptors to help control cancer progression. It may be prescribed alongside other treatments for comprehensive care.

Side Effects

  • Zercepac (trastuzumab) works by attaching to HER2 receptors on cancer cells, which can slow or stop their growth. Patients may experience fatigue, nausea, or headaches as common effects. These are typically monitored during treatment to ensure safety and comfort. Some individuals report chills or fever shortly after infusion, which are often temporary.

Precautions & Warnings

  • Zercepac (trastuzumab) should only be administered under medical supervision by healthcare professionals. Patients with known heart conditions or lung disease may require closer monitoring during treatment. It is important to disclose all current medications and health history before starting therapy. Regular cardiac function tests are often recommended to assess treatment impact.

Avoid Interactions

  • Zercepac (trastuzumab) may interact with other medications, including anthracyclines and certain chemotherapy drugs, which can affect heart function. Combining it with other HER2-targeted therapies should be done cautiously under medical guidance. Patients should avoid live vaccines during treatment unless approved by their doctor. Always consult a healthcare provider before starting or stopping any medications.

Frequently Asked Questions

Zercepac (trastuzumab) is used to treat HER2-positive breast cancer and HER2-positive metastatic gastric cancer.

Zercepac is given as an intravenous infusion under medical supervision in a clinical setting.

Common effects include fatigue, nausea, headaches, chills, or fever, which are typically monitored during treatment.

Live vaccines should be avoided during treatment unless approved by your healthcare provider.

Patients with heart conditions may require closer monitoring, as trastuzumab can affect heart function.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Trastuzumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT